US pharma giant seeks marketing authorisation from India for potential COVID-19 treatment drug
https://ift.tt/3gBywNF
US pharma giant Gilead Sciences has applied to India's drug regulator seeking marketing authorisation for its anti-viral drug remdesivir, which is being touted as a potential treatment for COVID-19. Gilead Sciences, who is the patent holder of the drug, has the complete data about the pre-clinical and clinical studies for remdesivir, sources said.
US pharma giant Gilead Sciences has applied to India's drug regulator seeking marketing authorisation for its anti-viral drug remdesivir, which is being touted as a potential treatment for COVID-19. Gilead Sciences, who is the patent holder of the drug, has the complete data about the pre-clinical and clinical studies for remdesivir, sources said.
No comments